Jasper Ridge Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Jasper Ridge Partners’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,184	Closed	-$270K	–	76
2018 Q3	$270K	Hold	9,184	–	–	0.01%	69
2018 Q2	$418K	Hold	9,184	–	–	0.03%	53
2018 Q1	$485K	Hold	9,184	–	–	0.03%	48
2017 Q4	$625K	Hold	9,184	–	–	0.04%	44
2017 Q3	$757K	Hold	9,184	–	–	0.04%	53
2017 Q2	$860K	Hold	9,184	–	–	0.05%	53
2017 Q1	$585K	Buy	9,184 +4,592	+100%	+$279K	0.04%	67
2016 Q4	$204K	Buy	+4,592	New	+$162K	0.01%	91
2015 Q4	–	Sell	-4,592	Closed	-$422K	–	93
2015 Q3	$422K	Sell	4,592 -9,643	-68%	-$835K	0.03%	69
2015 Q2	$1.25M	Buy	+14,235	New	+$1.22M	0.09%	49
2014 Q4	–	Sell	-8,495	Closed	-$385K	–	108
2014 Q3	$385K	Hold	8,495	–	–	0.03%	83
2014 Q2	$352K	Hold	8,495	–	–	0.02%	103
2014 Q1	$588K	Sell	8,495 -5,740	-40%	-$422K	0.04%	85
2013 Q4	$858K	Hold	14,235	–	–	0.05%	70
2013 Q3	$865K	Hold	14,235	–	–	0.05%	66
2013 Q2	$953K	Buy	+14,235	New	+$640K	0.06%	64

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return